@article{10.37349/eaa.2024.00061,
abstract = {Bronchiectasis is a heterogeneous chronic lung disease, characterised by irreversible dilatation of theairways and attributed to a wide spectrum of other underlying conditions, usually underdiagnosed andinadequately treated with a high burden for both the patients and the healthcare system. The waybronchiectasis is viewed by physicians has drastically changed over the last decades, with the topic ofeosinophilia in the context of the disease being one of the substantially highlighted. Eosinophilia wastraditionally considered as a means for distinguishing bronchiectasis from asthma, whereas bronchiectasiswas primarily associated with neutrophilic inflammation. However, eosinophilic bronchiectasis isnowadays identified as a distinct disease endotype and is associated with a specific clinical course andresponse to treatment. Further research is needed to better characterise this endotype and improve itspersonalised investigation and management in daily clinical practice.},
author = {Matthaiou, Andreas M and Bizymi, Nikoleta and Hillas, Georgios and Liapikou, Adamantia},
doi = {10.37349/eaa.2024.00061},
journal = {Exploration of Asthma & Allergy},
keywords = {bronchiectasis,eosinophil,eosinophilic inflammation},
pages = {502--510},
title = {{Eosinophilic inflammation in bronchiectasis : a wide-open field for future research}},
url = {https://www.explorationpub.com/Journals/eaa/Article/100961},
volume = {2},
year = {2024}，
number = {6}
}